Anteris Technologies Global Corp (AVR) - Cash Flow Conversion Efficiency

Latest as of September 2025: -5.434x

Based on the latest financial reports, Anteris Technologies Global Corp (AVR) has a cash flow conversion efficiency ratio of -5.434x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-18.25 Million ≈ $-12.91 Million USD) by net assets (AU$3.36 Million ≈ $2.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Anteris Technologies Global Corp defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Anteris Technologies Global Corp - Cash Flow Conversion Efficiency Trend (2003–2024)

This chart illustrates how Anteris Technologies Global Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Anteris Technologies Global Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anteris Technologies Global Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shanghai Haohai Biological Tech Co
SHG:688366
0.019x
Bajaj Consumer Care Limited
NSE:BAJAJCON
0.105x
Matrix Design Co. Ltd. A
SHE:301365
N/A
Guangdong Mingzhu Group Co Ltd
SHG:600382
0.035x
TrustCo Bank Corp NY
NASDAQ:TRST
0.018x
Kelsian Group Ltd
AU:KLS
0.087x
Suzhou Wanxiang Technology Co. Ltd.
SHE:301180
-0.059x
FPT Digital Retail JSC
VN:FRT
-0.473x

Annual Cash Flow Conversion Efficiency for Anteris Technologies Global Corp (2003–2024)

The table below shows the annual cash flow conversion efficiency of Anteris Technologies Global Corp from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see AVR market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$101.28 Million
≈ $71.66 Million
AU$-92.85 Million
≈ $-65.69 Million
-0.917x +48.91%
2023-12-31 AU$28.66 Million
≈ $20.28 Million
AU$-51.43 Million
≈ $-36.39 Million
-1.794x +39.18%
2022-12-31 AU$13.22 Million
≈ $9.35 Million
AU$-39.00 Million
≈ $-27.59 Million
-2.950x -125.04%
2021-12-31 AU$14.35 Million
≈ $10.15 Million
AU$-18.81 Million
≈ $-13.31 Million
-1.311x +78.04%
2020-12-31 AU$2.41 Million
≈ $1.70 Million
AU$-14.37 Million
≈ $-10.17 Million
-5.971x -305.64%
2019-12-31 AU$15.54 Million
≈ $10.99 Million
AU$-22.87 Million
≈ $-16.18 Million
-1.472x -42.38%
2018-12-31 AU$21.48 Million
≈ $15.20 Million
AU$-22.21 Million
≈ $-15.71 Million
-1.034x -29.73%
2017-12-31 AU$16.63 Million
≈ $11.77 Million
AU$-13.25 Million
≈ $-9.38 Million
-0.797x -53.20%
2016-12-31 AU$23.97 Million
≈ $16.96 Million
AU$-12.47 Million
≈ $-8.82 Million
-0.520x +46.33%
2015-12-31 AU$22.64 Million
≈ $16.02 Million
AU$-21.94 Million
≈ $-15.52 Million
-0.969x -73.83%
2014-12-31 AU$38.56 Million
≈ $27.28 Million
AU$-21.50 Million
≈ $-15.21 Million
-0.557x -94.66%
2013-12-31 AU$37.17 Million
≈ $26.30 Million
AU$-10.64 Million
≈ $-7.53 Million
-0.286x -16.77%
2012-12-31 AU$15.08 Million
≈ $10.67 Million
AU$-3.70 Million
≈ $-2.62 Million
-0.245x +27.63%
2011-12-31 AU$10.43 Million
≈ $7.38 Million
AU$-3.54 Million
≈ $-2.50 Million
-0.339x -214.22%
2010-12-31 AU$13.64 Million
≈ $9.65 Million
AU$-1.47 Million
≈ $-1.04 Million
-0.108x +89.22%
2009-12-31 AU$1.24 Million
≈ $876.86K
AU$-1.24 Million
≈ $-877.07K
-1.000x -10.44%
2008-12-31 AU$1.10 Million
≈ $776.94K
AU$-994.45K
≈ $-703.63K
-0.906x -36.45%
2007-12-31 AU$1.39 Million
≈ $982.53K
AU$-921.64K
≈ $-652.12K
-0.664x -3.07%
2006-12-31 AU$2.34 Million
≈ $1.65 Million
AU$-1.51 Million
≈ $-1.07 Million
-0.644x -306.28%
2005-12-31 AU$3.37 Million
≈ $2.39 Million
AU$-534.48K
≈ $-378.18K
-0.158x +16.30%
2004-12-31 AU$3.81 Million
≈ $2.69 Million
AU$-720.48K
≈ $-509.79K
-0.189x -62.56%
2003-12-31 AU$5.01 Million
≈ $3.55 Million
AU$-583.85K
≈ $-413.11K
-0.116x --

About Anteris Technologies Global Corp

AU:AVR Australia Medical Devices
Market Cap
$925.12 Million
AU$1.31 Billion AUD
Market Cap Rank
#9815 Global
#246 in Australia
Share Price
AU$13.50
Change (1 day)
+2.66%
52-Week Range
AU$4.69 - AU$13.80
All Time High
AU$83.50
About

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calci… Read more